Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04895735
Title Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic
Indications

salivary gland cancer

Therapies

Pembrolizumab + Pemetrexed Disodium

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic in Arizona Recruiting Scottsdale Arizona 85259 United States Details
Mayo Clinic in Florida Recruiting Jacksonville Florida 32224-9980 United States Details
Mayo Clinic in Rochester Recruiting Rochester Minnesota 55905 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field